Could be read as no claims of efficacy may be made....unless... (insert Biomarker evidence here). Set up for stage 1-6 AD, something like cancer structure? New guidance might explain why the BP's bailed out a while back. Now of course some questions could be asked about BIIB's AD current effort. Does this mean the trains are not leaving (ANY) station for AD trials in the near future?
News 
Market Data 
Discover 
